Nicolas N. Nassar
@nicolasnassar3
We study RAC GTPases, the role of the RacGEF VAV3 in leukemia, drug design and development, and protein structures. Opinions are mine.
ID: 2738379174
16-08-2014 23:17:42
1,1K Tweet
220 Takipçi
319 Takip Edilen
Celebrating Dr. Jose Cancelas' achievement. Jose - on the left - is a friend and colleague and a true scholar. He is moving to Dana-Farber I wish him best of luck. He'll be missed.
New review from our group UC General Surgery Residents UC College of Medicine comparing and contrasting mutant-selective-, pan-KRAS, and RAS(MULTI)ON-selective RAS inhibitors in pancreatic cancer with standards of care: Szu-Aun Long Syed A. Ahmad Amber Amparo Grace Goodhart frontiersin.org/journals/oncol…
📢 Excited to share the Special Issue "Acute Myeloid Leukemia in Adults (2nd Edition)", edited by Dr. Theodoros Karantanos Johns Hopkins University, now open for submissions!👏 📝 Deadline for manuscript submissions: 31 August 2026. 🔗More details here: mdpi.com/journal/cancer…
📑Happy to share the Special issue "Ras-Directed Therapies: A Revolution" edited by Dr. Naiara Perurena IIS Aragón👏 📆Deadline for manuscript submissions: 30 June 2026. Find more details here➡️ mdpi.com/journal/cancer…
📢We're Excited to share the #SpecialIssue "Current Research in #Pediatric Hematological Oncology" edited by Dr. Santhosh Kumar Pasupuleti & Dr. Tzu-Chieh Ho, now open for submissions! 👏 IU School of Medicine Find more details here: 📌mdpi.com/journal/cancer…